Howard Hughes (HHH) Competitors $75.49 +2.87 (+3.95%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$75.57 +0.08 (+0.11%) As of 08/22/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HHH vs. TSHA, ZG, WPC, HLI, REG, GLPI, AMH, JEF, DOC, and HSTShould you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Taysha Gene Therapies (TSHA), Zillow Group (ZG), W.P. Carey (WPC), Houlihan Lokey (HLI), Regency Centers (REG), Gaming and Leisure Properties (GLPI), American Homes 4 Rent (AMH), Jefferies Financial Group (JEF), Healthpeak Properties (DOC), and Host Hotels & Resorts (HST). Howard Hughes vs. Its Competitors Taysha Gene Therapies Zillow Group W.P. Carey Houlihan Lokey Regency Centers Gaming and Leisure Properties American Homes 4 Rent Jefferies Financial Group Healthpeak Properties Host Hotels & Resorts Taysha Gene Therapies (NASDAQ:TSHA) and Howard Hughes (NYSE:HHH) are related companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Do analysts rate TSHA or HHH? Taysha Gene Therapies presently has a consensus target price of $8.29, indicating a potential upside of 176.19%. Howard Hughes has a consensus target price of $80.33, indicating a potential upside of 6.42%. Given Taysha Gene Therapies' stronger consensus rating and higher possible upside, research analysts clearly believe Taysha Gene Therapies is more favorable than Howard Hughes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Taysha Gene Therapies 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00Howard Hughes 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders and institutionals hold more shares of TSHA or HHH? 77.7% of Taysha Gene Therapies shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 3.8% of Taysha Gene Therapies shares are held by company insiders. Comparatively, 33.0% of Howard Hughes shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is TSHA or HHH more profitable? Howard Hughes has a net margin of 12.85% compared to Taysha Gene Therapies' net margin of -1,144.97%. Howard Hughes' return on equity of 10.51% beat Taysha Gene Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Taysha Gene Therapies-1,144.97% -78.44% -44.82% Howard Hughes 12.85%10.51%3.15% Does the media prefer TSHA or HHH? In the previous week, Howard Hughes had 2 more articles in the media than Taysha Gene Therapies. MarketBeat recorded 10 mentions for Howard Hughes and 8 mentions for Taysha Gene Therapies. Howard Hughes' average media sentiment score of 1.22 beat Taysha Gene Therapies' score of 0.40 indicating that Howard Hughes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Taysha Gene Therapies 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Howard Hughes 7 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, TSHA or HHH? Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTaysha Gene Therapies$8.10M79.52-$89.30M-$0.34-8.82Howard Hughes$1.75B2.56$200.55M$4.5716.52 Which has more risk & volatility, TSHA or HHH? Taysha Gene Therapies has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Comparatively, Howard Hughes has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. SummaryHoward Hughes beats Taysha Gene Therapies on 12 of the 16 factors compared between the two stocks. Get Howard Hughes News Delivered to You Automatically Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HHH vs. The Competition Export to ExcelMetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE ExchangeMarket Cap$4.31B$2.75B$12.41B$20.93BDividend YieldN/A2.85%5.52%3.57%P/E Ratio16.5211.8419.4029.17Price / Sales2.563.6026.3672.69Price / Cash7.4927.0021.7523.54Price / Book1.591.012.355.47Net Income$200.55M-$106.17M$1.01B$992.74M7 Day Performance2.40%1.98%1.75%2.68%1 Month Performance7.49%5.91%1.03%1.53%1 Year Performance1.04%3.54%537.36%10.77% Howard Hughes Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HHHHoward Hughes2.3252 of 5 stars$75.49+4.0%$80.33+6.4%+4.6%$4.31B$1.75B16.52608News CoveragePositive NewsTSHATaysha Gene Therapies3.4032 of 5 stars$2.76+1.5%$8.17+195.9%+33.9%$583.88M$8.33M-8.12180ZGZillow Group4.146 of 5 stars$76.12-1.8%$85.62+12.5%+61.9%$18.71B$2.24B-292.776,856Short Interest ↓WPCW.P. Carey3.2461 of 5 stars$65.60-0.4%$65.00-0.9%+12.6%$14.43B$1.58B43.16190Positive NewsAnalyst ForecastShort Interest ↑HLIHoulihan Lokey4.7274 of 5 stars$190.34+0.8%$206.40+8.4%+28.8%$13.18B$2.39B32.041,100News CoveragePositive NewsShort Interest ↓REGRegency Centers3.9397 of 5 stars$71.54-0.5%$77.92+8.9%+2.3%$13.06B$1.45B33.43440News CoveragePositive NewsAnalyst ForecastGLPIGaming and Leisure Properties4.3602 of 5 stars$45.54-0.8%$53.16+16.7%-3.2%$12.99B$1.53B17.6520News CoveragePositive NewsAnalyst ForecastAMHAmerican Homes 4 Rent4.2113 of 5 stars$34.23-0.6%$40.90+19.5%-6.8%$12.77B$1.73B30.831,730News CoveragePositive NewsDividend AnnouncementAnalyst ForecastJEFJefferies Financial Group4.2708 of 5 stars$58.89+0.7%$66.00+12.1%+8.9%$12.06B$7.03B22.227,822Trending NewsDOCHealthpeak Properties4.7371 of 5 stars$16.79-1.0%$23.00+37.0%-19.9%$11.79B$2.70B69.94200News CoveragePositive NewsDividend AnnouncementAnalyst ForecastHSTHost Hotels & Resorts3.9186 of 5 stars$15.31-0.3%$17.50+14.3%-1.1%$10.55B$5.68B16.29160News CoveragePositive NewsAnalyst Revision Related Companies and Tools Related Companies Taysha Gene Therapies Competitors Zillow Group Competitors W.P. Carey Competitors Houlihan Lokey Competitors Regency Centers Competitors Gaming and Leisure Properties Competitors American Homes 4 Rent Competitors Jefferies Financial Group Competitors Healthpeak Properties Competitors Host Hotels & Resorts Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HHH) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Howard Hughes Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Howard Hughes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access